D-0024-2026 Class III Ongoing
FDA drug recall D-0024-2026 was initiated by STAQ Pharma, Inc. on Oct 9, 2025 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 22, 2025
- Initiation Date
- Oct 9, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date
Distribution pattern
Nationwide in the U.S.
Code information
Lot #: 25156673A, Expiry: 02FEB2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0024-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026